These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 9484812

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Resistance to microtubule-targeted cytotoxins in a K562 leukemia cell variant associated with altered tubulin expression and polymerization.
    Dumontet C, Jaffrezou JP, Tsuchiya E, Duran GE, Chen KG, Derry WB, Wilson L, Jordan MA, Sikic BI.
    Bull Cancer; 2004 May; 91(5):E81-112. PubMed ID: 15568225
    [Abstract] [Full Text] [Related]

  • 26. Mechanism of action of ixabepilone and its interactions with the βIII-tubulin isotype.
    Lopus M, Smiyun G, Miller H, Oroudjev E, Wilson L, Jordan MA.
    Cancer Chemother Pharmacol; 2015 Nov; 76(5):1013-24. PubMed ID: 26416565
    [Abstract] [Full Text] [Related]

  • 27. Mechanism of paclitaxel resistance in a human prostate cancer cell line, PC3-PR, and its sensitization by cabazitaxel.
    Sobue S, Mizutani N, Aoyama Y, Kawamoto Y, Suzuki M, Nozawa Y, Ichihara M, Murate T.
    Biochem Biophys Res Commun; 2016 Oct 28; 479(4):808-813. PubMed ID: 27687545
    [Abstract] [Full Text] [Related]

  • 28. Survival of docetaxel-resistant prostate cancer cells in vitro depends on phenotype alterations and continuity of drug exposure.
    Makarovskiy AN, Siryaporn E, Hixson DC, Akerley W.
    Cell Mol Life Sci; 2002 Jul 28; 59(7):1198-211. PubMed ID: 12222966
    [Abstract] [Full Text] [Related]

  • 29. Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes.
    Kavallaris M, Kuo DY, Burkhart CA, Regl DL, Norris MD, Haber M, Horwitz SB.
    J Clin Invest; 1997 Sep 01; 100(5):1282-93. PubMed ID: 9276747
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Delineating the interaction of combretastatin A-4 with αβ tubulin isotypes present in drug resistant human lung carcinoma using a molecular modeling approach.
    Kumbhar BV, Bhandare VV, Panda D, Kunwar A.
    J Biomol Struct Dyn; 2020 Feb 01; 38(2):426-438. PubMed ID: 30831055
    [Abstract] [Full Text] [Related]

  • 33. Effects of the herbal extract PC-SPES on microtubule dynamics and paclitaxel-mediated prostate tumor growth inhibition.
    Bonham MJ, Galkin A, Montgomery B, Stahl WL, Agus D, Nelson PS.
    J Natl Cancer Inst; 2002 Nov 06; 94(21):1641-7. PubMed ID: 12419791
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Bcl-2 down-regulation and tubulin subtype composition are involved in resistance of ovarian cancer cells to vinflunine.
    Estève MA, Carré M, Bourgarel-Rey V, Kruczynski A, Raspaglio G, Ferlini C, Braguer D.
    Mol Cancer Ther; 2006 Nov 06; 5(11):2824-33. PubMed ID: 17121929
    [Abstract] [Full Text] [Related]

  • 36. Paclitaxel resistance in cells with reduced beta-tubulin.
    Wang Y, Cabral F.
    Biochim Biophys Acta; 2005 Jun 30; 1744(2):245-55. PubMed ID: 15950754
    [Abstract] [Full Text] [Related]

  • 37. Class III beta-tubulin mediates sensitivity to chemotherapeutic drugs in non small cell lung cancer.
    Gan PP, Pasquier E, Kavallaris M.
    Cancer Res; 2007 Oct 01; 67(19):9356-63. PubMed ID: 17909044
    [Abstract] [Full Text] [Related]

  • 38. Mutations in alpha- and beta-tubulin that stabilize microtubules and confer resistance to colcemid and vinblastine.
    Hari M, Wang Y, Veeraraghavan S, Cabral F.
    Mol Cancer Ther; 2003 Jul 01; 2(7):597-605. PubMed ID: 12883031
    [Abstract] [Full Text] [Related]

  • 39. DTA0100, dual topoisomerase II and microtubule inhibitor, evades paclitaxel resistance in P-glycoprotein overexpressing cancer cells.
    Podolski-Renić A, Banković J, Dinić J, Ríos-Luci C, Fernandes MX, Ortega N, Kovačević-Grujičić N, Martín VS, Padrón JM, Pešić M.
    Eur J Pharm Sci; 2017 Jul 15; 105():159-168. PubMed ID: 28502672
    [Abstract] [Full Text] [Related]

  • 40. Septin filament coalignment with microtubules depends on SEPT9_i1 and tubulin polyglutamylation, and is an early feature of acquired cell resistance to paclitaxel.
    Targa B, Klipfel L, Cantaloube I, Salameh J, Benoit B, Poüs C, Baillet A.
    Cell Death Dis; 2019 Jan 22; 10(2):54. PubMed ID: 30670682
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.